Abstract

OBJECTIVES

Reported early outcomes for patients undergoing reoperations on the aortic root are worse than those for patients undergoing first-time surgery. The aim of this study was to review our experience with aortic root surgery by stratifying outcomes according to the type of intervention: reoperation versus primary operation on the aortic root.

METHODS

Of the 1267 patients undergoing aortic root surgery, 180 underwent aortic reoperation with root replacement (ARR) and 1087 underwent primary root replacement (PRR). Treatment bias was addressed by the use of propensity score (PS) matching and multivariate regression analysis. After PS matching, two groups of 116 patients each were created (ARR versus PRR). The primary end-points were in-hospital mortality and occurrence of postoperative complications.

RESULTS

In the unmatched cohort, hospital mortality and postoperative complications rates were higher in the ARR group than in the PRR group (11.1 vs 4.1%, P < 0.001; 22.2 vs 15.1%, P = 0.02). Early results were greatly affected by the type of aortic disease. The in-hospital mortality rate was 3.1% for degenerative aneurysm, 13.3% for chronic dissection, 14% for acute dissection, 16.7% for active endocarditis and 25% for false aneurysm (P < 0.001). In the propensity-matched cohort, no significant differences were observed between the groups in terms of hospital mortality rate (ARR: 6%; PRR: 1.7%; P= 0.2) and postoperative complications (ARR: 16.4%; PRR: 14.7%; P = 0.9). Logistic regression analysis revealed cardiopulmonary bypass (CPB) time [odds ratio (OR): 1.03 per min; P < 0.001] and urgent/emergent status (OR: 6.4; P = 0.04) as independent risk factors for hospital deaths. Age (OR: 1.07 per year; P = 0.03) was the sole independent predictor of postoperative complications.

CONCLUSIONS

During root surgery, reintervention did not affect early outcomes and was associated with satisfactory mortality and morbidity rates. In this setting, hospital results were heavily influenced by aortic pathology and the patient's profile.

INTRODUCTION

Over the years, the incidence of reinterventions on the thoracic aorta has risen significantly [13]. In the literature, reported early results for patients undergoing reoperations on the aortic root are poorer than those for patients undergoing first-time surgery [410]. However, published outcomes of aortic reoperations versus primary operations are based on only a few (although valuable) studies providing data jeopardized by several sources of bias [4, 5].

The aim of this study was to review our experience with aortic root surgery by stratifying outcomes according to the type of intervention: reoperation versus primary operation on the aortic root. Statistical methods were used to control for treatment-selection bias.

PATIENTS AND METHODS

Study population

Our prospectively maintained clinical database was used to identify 1267 consecutive patients who underwent aortic root surgery at Sant'Orsola-Malpighi Hospital (Bologna, Italy) between 1986 and 2014. We divided the 1267 patients into two groups according to the type of intervention for the comparison of hospital outcomes: aortic reoperation with root replacement (ARR, n = 180) versus primary root replacement (PRR, n = 1087). Patients who had previously undergone non-aortic operations (e.g. mitral valve surgery, coronary bypass surgery) were excluded from the study to decrease undesired bias. Prior aortic interventions of ARR patients are depicted in Table 1. At least one prior aortic redo procedure had been performed in 23 (12.8%) patients, and the mean interval between the last previous operation and the actual reintervention was 11 ± 9 years.

Table 1:

Prior aortic interventions in ARR patients (n = 180)

InterventionFrequency%
AVR8044.4
AVR + supracoronary aorta replacement73.9
AVR + supracoronary aorta reduction52.8
AVR + supracoronary aorta + arch replacement10.6
AVP42.2
AVR + supracoronary aorta replacement84.4
AVR + supracoronary aorta reduction10.6
Bentall procedure2413.3
Supracoronary aorta replacement3313.3
Supracoronary aorta reduction10.6
Supracoronary aorta + hemiarch replacement116.1
Supracoronary aorta + arch replacement + ET31.7
Supracoronary aorta + arch replacement + FET10.6
Pulmonary autograft10.6
Associated procedures
 CABG95
 MVP10.6
 MVR42.2
InterventionFrequency%
AVR8044.4
AVR + supracoronary aorta replacement73.9
AVR + supracoronary aorta reduction52.8
AVR + supracoronary aorta + arch replacement10.6
AVP42.2
AVR + supracoronary aorta replacement84.4
AVR + supracoronary aorta reduction10.6
Bentall procedure2413.3
Supracoronary aorta replacement3313.3
Supracoronary aorta reduction10.6
Supracoronary aorta + hemiarch replacement116.1
Supracoronary aorta + arch replacement + ET31.7
Supracoronary aorta + arch replacement + FET10.6
Pulmonary autograft10.6
Associated procedures
 CABG95
 MVP10.6
 MVR42.2

ARR: aortic root reoperation; AVP: aortic valve plasty; AVR: aortic valve replacement; CABG: coronary artery bypass grafting; hemiarch replacement: partial arch replacement without reimplantation of arch vessels; ET: elephant trunk; FET: frozen elephant trunk; MVP: mitral valve plasty; MVR: mitral valve replacement.

Table 1:

Prior aortic interventions in ARR patients (n = 180)

InterventionFrequency%
AVR8044.4
AVR + supracoronary aorta replacement73.9
AVR + supracoronary aorta reduction52.8
AVR + supracoronary aorta + arch replacement10.6
AVP42.2
AVR + supracoronary aorta replacement84.4
AVR + supracoronary aorta reduction10.6
Bentall procedure2413.3
Supracoronary aorta replacement3313.3
Supracoronary aorta reduction10.6
Supracoronary aorta + hemiarch replacement116.1
Supracoronary aorta + arch replacement + ET31.7
Supracoronary aorta + arch replacement + FET10.6
Pulmonary autograft10.6
Associated procedures
 CABG95
 MVP10.6
 MVR42.2
InterventionFrequency%
AVR8044.4
AVR + supracoronary aorta replacement73.9
AVR + supracoronary aorta reduction52.8
AVR + supracoronary aorta + arch replacement10.6
AVP42.2
AVR + supracoronary aorta replacement84.4
AVR + supracoronary aorta reduction10.6
Bentall procedure2413.3
Supracoronary aorta replacement3313.3
Supracoronary aorta reduction10.6
Supracoronary aorta + hemiarch replacement116.1
Supracoronary aorta + arch replacement + ET31.7
Supracoronary aorta + arch replacement + FET10.6
Pulmonary autograft10.6
Associated procedures
 CABG95
 MVP10.6
 MVR42.2

ARR: aortic root reoperation; AVP: aortic valve plasty; AVR: aortic valve replacement; CABG: coronary artery bypass grafting; hemiarch replacement: partial arch replacement without reimplantation of arch vessels; ET: elephant trunk; FET: frozen elephant trunk; MVP: mitral valve plasty; MVR: mitral valve replacement.

The distribution of reinterventions and primary operations throughout the study period is shown in Fig. 1.
Distribution of reoperations (ARR) and primary operations (PRR) throughout the study period (P = 0.1). ARR: aortic reoperation with root replacement; PRR: primary root replacement.
Figure 1:

Distribution of reoperations (ARR) and primary operations (PRR) throughout the study period (P = 0.1). ARR: aortic reoperation with root replacement; PRR: primary root replacement.

Approval from the institutional review board was obtained.

Surgical technique

The aorta was exposed through a standard sternotomy in all patients. Vessel selection for arterial cannulation for cardiopulmonary bypass (CPB) depended upon the presence of aortic dissection, atheromatous disease, the extent of the aortic replacement and the degree of safety at chest re-entry. In general, when surgery was limited to the root/ascending aorta and a low-risk resternotomy was anticipated, CPB arterial inflow was obtained by cannulating the distal ascending aorta or the aortic arch. In patients who required some degree of aortic arch replacement, our favourite site for arterial cannulation was the right axillary artery or the innominate artery, mainly because they facilitate antegrade cerebral perfusion. The femoral artery was cannulated in patients who required CPB before resternotomy when an axillary artery was unavailable for cannulation or in unstable patients when prompt initiation of CPB became necessary. The right atrium, the common femoral vein or both venae cavae were used for venous return. The left heart was vented through insertion of a catheter in the right superior pulmonary vein, in the pulmonary artery trunk or in the left ventricular apex. Cold crystalloid cardioplegic solution was used in all cases. In ARR patients determined to be at high risk of chest re-entry lesion [2], resternotomy was performed on CPB (n = 7; 3.9%) or under deep hypothermic circulatory arrest (nasopharyngeal 18°C) (n = 3; 1.7%). In these patients, if significant aortic insufficiency was present, the apex of the left ventricle was cannulated before resternotomy (through a left anterior minithoracotomy) to avoid left ventricle distension (n = 5; 2.8%). In all cases involving partial or total aortic arch replacement or in patients in whom resternotomy was performed under circulatory arrest, antegrade selective cerebral perfusion (ASCP) was used for cerebral protection [11].

Aortic root operations included the Bentall procedure [12, 13], the Cabrol procedure [14] or prosthesis-sparing intervention [15]. The latter was performed in ARR patients with a prior well-functioning aortic valve prosthesis. In patients who underwent aortic arch reconstruction, the ‘en bloc technique’ or the ‘separated graft technique’ was used as a method of arch vessel reimplantation [16]. A conventional or a frozen elephant trunk procedure [17] was performed in patients with a diseased descending thoracic aorta.

Objectives of the study and analytic plan

The main purpose of this study was to compare hospital outcomes after aortic root surgery in patients who underwent aortic reoperation with root replacement versus those who underwent primary root replacement. Treatment bias was addressed by the use of propensity score (PS) matching and multivariate regression analysis. Second, using multivariable logistic models, we sought to identify the independent predictors of hospital deaths and major postoperative complications [permanent neurological deficit (PND), mechanical ventilation >72 h, acute myocardial infarction, temporary/permanent dialysis, bleeding requiring chest reopening and sepsis]. Covariate balance was measured using the standardized differences between the two treatment groups, which were calculated as the differences in the means divided by the pooled standard deviation and expressed as a percentage. A standardized difference greater than 10% is suggested to represent a meaningful covariate imbalance [18]. The primary end-points were all-cause mortality and occurrence of postoperative complications during hospitalization. In accordance with recent recommendations [18], differences in mortality rates and occurrence of postoperative complications between treatment groups were reported in terms of absolute risk reduction (AbRR) and odds ratios (OR). A two-sided probability value less than 0.05 was considered statistically significant. All analyses were performed with the SPSS 20.0 software (SPSS, Chicago, IL).

Propensity score matching

A PS was calculated for each patient using a non-parsimonious multivariable logistic regression, with reoperation as the dependent variable; it incorporated 20 preoperative covariates and 1 intraoperative relevant covariate as the independent variable (Table 2). Patients undergoing reoperative surgery were matched on a one-to-one basis with patients undergoing first-time surgery on the basis of the PS, by the use of nearest-neighbour matching without replacement, and a matching tolerance (caliper) of 0.2.

Table 2:

Patients' characteristics (n = 1267)

CharacteristicsOverall cohort
Propensity-matched cohort
ARR (n = 180)PRR (n = 1087)Standardized differenceaARR (n = 116)PRR (n = 116)Standardized differencea
Female gender20.619.81.921.622.4−2.1
Age (mean, years)57.459.7−16.956.856.9−0.7
Hypertension60.666.5−12.25651.78.8
Diabetes6.712.8−24.568.6−9.3
Obesity4.48.1−17.14.34.9−6.4
Smoking3345.3−26.132.2312.6
Chronic pulmonary disease9.57.85.78.77.83.2
Renal failure4.43.16.32.62.60
Bicuspid aortic valve11.734.4−70.116.414.75.4
Marfan syndrome5.63.97.35.23.57.4
NYHA III–IV22.628.2−13.122.420.24.3
Coronary artery disease15.614.8213.810.69.2
Cerebrovascular disease3.94.2−1.45.23.58.5
Peripheral vascular disease1.13.1−18.21.74.1−9.1
Urgent/emergency surgery18.910.720.911.216.4−9.2
Indications for reoperation
 Degenerative aneurysm49.488.7−78.374.174.10
 TAAD3.99.2−27.468.6−9.3
 Chronic post-dissection aneurysm251.454.414.712.94
 False aneurysm1033.20.92.9
 Endocarditis12.20.7354.34.30
Extent of aortic repair
 Root66.185.941.771.669.8−3.6
 Root + arch33.914.141.728.430.2−3.6
CharacteristicsOverall cohort
Propensity-matched cohort
ARR (n = 180)PRR (n = 1087)Standardized differenceaARR (n = 116)PRR (n = 116)Standardized differencea
Female gender20.619.81.921.622.4−2.1
Age (mean, years)57.459.7−16.956.856.9−0.7
Hypertension60.666.5−12.25651.78.8
Diabetes6.712.8−24.568.6−9.3
Obesity4.48.1−17.14.34.9−6.4
Smoking3345.3−26.132.2312.6
Chronic pulmonary disease9.57.85.78.77.83.2
Renal failure4.43.16.32.62.60
Bicuspid aortic valve11.734.4−70.116.414.75.4
Marfan syndrome5.63.97.35.23.57.4
NYHA III–IV22.628.2−13.122.420.24.3
Coronary artery disease15.614.8213.810.69.2
Cerebrovascular disease3.94.2−1.45.23.58.5
Peripheral vascular disease1.13.1−18.21.74.1−9.1
Urgent/emergency surgery18.910.720.911.216.4−9.2
Indications for reoperation
 Degenerative aneurysm49.488.7−78.374.174.10
 TAAD3.99.2−27.468.6−9.3
 Chronic post-dissection aneurysm251.454.414.712.94
 False aneurysm1033.20.92.9
 Endocarditis12.20.7354.34.30
Extent of aortic repair
 Root66.185.941.771.669.8−3.6
 Root + arch33.914.141.728.430.2−3.6

ARR: aortic root reoperation; NYHA: New York Heart Association; PRR: primary root replacement; TAAD: type A acute aortic dissection.

aStandardized difference is the mean difference divided by the pooled standard deviation, expressed as percentage. Values are percentages unless otherwise indicated.

Table 2:

Patients' characteristics (n = 1267)

CharacteristicsOverall cohort
Propensity-matched cohort
ARR (n = 180)PRR (n = 1087)Standardized differenceaARR (n = 116)PRR (n = 116)Standardized differencea
Female gender20.619.81.921.622.4−2.1
Age (mean, years)57.459.7−16.956.856.9−0.7
Hypertension60.666.5−12.25651.78.8
Diabetes6.712.8−24.568.6−9.3
Obesity4.48.1−17.14.34.9−6.4
Smoking3345.3−26.132.2312.6
Chronic pulmonary disease9.57.85.78.77.83.2
Renal failure4.43.16.32.62.60
Bicuspid aortic valve11.734.4−70.116.414.75.4
Marfan syndrome5.63.97.35.23.57.4
NYHA III–IV22.628.2−13.122.420.24.3
Coronary artery disease15.614.8213.810.69.2
Cerebrovascular disease3.94.2−1.45.23.58.5
Peripheral vascular disease1.13.1−18.21.74.1−9.1
Urgent/emergency surgery18.910.720.911.216.4−9.2
Indications for reoperation
 Degenerative aneurysm49.488.7−78.374.174.10
 TAAD3.99.2−27.468.6−9.3
 Chronic post-dissection aneurysm251.454.414.712.94
 False aneurysm1033.20.92.9
 Endocarditis12.20.7354.34.30
Extent of aortic repair
 Root66.185.941.771.669.8−3.6
 Root + arch33.914.141.728.430.2−3.6
CharacteristicsOverall cohort
Propensity-matched cohort
ARR (n = 180)PRR (n = 1087)Standardized differenceaARR (n = 116)PRR (n = 116)Standardized differencea
Female gender20.619.81.921.622.4−2.1
Age (mean, years)57.459.7−16.956.856.9−0.7
Hypertension60.666.5−12.25651.78.8
Diabetes6.712.8−24.568.6−9.3
Obesity4.48.1−17.14.34.9−6.4
Smoking3345.3−26.132.2312.6
Chronic pulmonary disease9.57.85.78.77.83.2
Renal failure4.43.16.32.62.60
Bicuspid aortic valve11.734.4−70.116.414.75.4
Marfan syndrome5.63.97.35.23.57.4
NYHA III–IV22.628.2−13.122.420.24.3
Coronary artery disease15.614.8213.810.69.2
Cerebrovascular disease3.94.2−1.45.23.58.5
Peripheral vascular disease1.13.1−18.21.74.1−9.1
Urgent/emergency surgery18.910.720.911.216.4−9.2
Indications for reoperation
 Degenerative aneurysm49.488.7−78.374.174.10
 TAAD3.99.2−27.468.6−9.3
 Chronic post-dissection aneurysm251.454.414.712.94
 False aneurysm1033.20.92.9
 Endocarditis12.20.7354.34.30
Extent of aortic repair
 Root66.185.941.771.669.8−3.6
 Root + arch33.914.141.728.430.2−3.6

ARR: aortic root reoperation; NYHA: New York Heart Association; PRR: primary root replacement; TAAD: type A acute aortic dissection.

aStandardized difference is the mean difference divided by the pooled standard deviation, expressed as percentage. Values are percentages unless otherwise indicated.

RESULTS

Patients' characteristics and intraoperative data

In the unmatched cohort, the ARR patients were younger than the PRR patients (57.4 vs 59.7 years; P = 0.03) and were more likely to undergo urgent/emergent operations (18.9 vs 10.7%; P = 0.003). When compared with PRR patients, ARR patients were more likely to have acute endocarditis (12.2 vs 0.7%; P < 0.001), a false aneurysm (10 vs 0%; P < 0.001) and a chronic post-dissection aneurysm (25 vs 1.4%; P < 0.001) and less likely to have a degenerative aneurysm (49.4 vs 88.7%; P < 0.001) and an acute type A aortic dissection (3.9 vs 9.2%; P = 0.01) (Table 2). Intraoperatively, the PRR group was more frequently associated with a less extensive aortic replacement and a shorter period of CPB, myocardial ischaemia and ASCP (Table 3). Total arch replacement using the elephant trunk or the frozen elephant trunk technique was performed in 18 (10%) ARR patients and 15 (1.4%) PRR patients (P < 0.001).

Table 3:

Operative data (n = 1267)

CharacteristicsOverall cohort
Propensity-matched cohort
ARR (n = 180)PRR (n = 1087)P-valueARR (n = 116)PRR (n = 116)P-value
Extent of aortic repair
 Root66.185.9<0.00171.669.80.9
 Root + arch33.914.1<0.00128.430.20.9
Root procedures
 Bentall77.898.7<0.00171.698.4<0.001
 Cabrol2.21.30.31.71.71
 Prosthesis sparing18.3-<0.00126.7-<0.001
Associated procedures15.619.10.312.915.50.7
Unplanned CABG2.82.40.81.72.61
CPB time (mean; minutes)213.7151.7<0.001192160.9<0.001
Cross-clamp time (mean; minutes)153.5117.3<0.001142.3122.7<0.001
ASCP time62.644.2<0.00155.444.60.1
CharacteristicsOverall cohort
Propensity-matched cohort
ARR (n = 180)PRR (n = 1087)P-valueARR (n = 116)PRR (n = 116)P-value
Extent of aortic repair
 Root66.185.9<0.00171.669.80.9
 Root + arch33.914.1<0.00128.430.20.9
Root procedures
 Bentall77.898.7<0.00171.698.4<0.001
 Cabrol2.21.30.31.71.71
 Prosthesis sparing18.3-<0.00126.7-<0.001
Associated procedures15.619.10.312.915.50.7
Unplanned CABG2.82.40.81.72.61
CPB time (mean; minutes)213.7151.7<0.001192160.9<0.001
Cross-clamp time (mean; minutes)153.5117.3<0.001142.3122.7<0.001
ASCP time62.644.2<0.00155.444.60.1

ARR: aortic root reoperation; ASCP: antegrade selective cerebral perfusion; CABG: coronary artery bypass grafting; CPB: cardiopulmonary bypass; PRR: primary root replacement.

Table 3:

Operative data (n = 1267)

CharacteristicsOverall cohort
Propensity-matched cohort
ARR (n = 180)PRR (n = 1087)P-valueARR (n = 116)PRR (n = 116)P-value
Extent of aortic repair
 Root66.185.9<0.00171.669.80.9
 Root + arch33.914.1<0.00128.430.20.9
Root procedures
 Bentall77.898.7<0.00171.698.4<0.001
 Cabrol2.21.30.31.71.71
 Prosthesis sparing18.3-<0.00126.7-<0.001
Associated procedures15.619.10.312.915.50.7
Unplanned CABG2.82.40.81.72.61
CPB time (mean; minutes)213.7151.7<0.001192160.9<0.001
Cross-clamp time (mean; minutes)153.5117.3<0.001142.3122.7<0.001
ASCP time62.644.2<0.00155.444.60.1
CharacteristicsOverall cohort
Propensity-matched cohort
ARR (n = 180)PRR (n = 1087)P-valueARR (n = 116)PRR (n = 116)P-value
Extent of aortic repair
 Root66.185.9<0.00171.669.80.9
 Root + arch33.914.1<0.00128.430.20.9
Root procedures
 Bentall77.898.7<0.00171.698.4<0.001
 Cabrol2.21.30.31.71.71
 Prosthesis sparing18.3-<0.00126.7-<0.001
Associated procedures15.619.10.312.915.50.7
Unplanned CABG2.82.40.81.72.61
CPB time (mean; minutes)213.7151.7<0.001192160.9<0.001
Cross-clamp time (mean; minutes)153.5117.3<0.001142.3122.7<0.001
ASCP time62.644.2<0.00155.444.60.1

ARR: aortic root reoperation; ASCP: antegrade selective cerebral perfusion; CABG: coronary artery bypass grafting; CPB: cardiopulmonary bypass; PRR: primary root replacement.

Overall in-hospital outcomes

Sixty-five patients died during hospitalization, for an overall in-hospital mortality rate of 5.1%. The mortality rates among the elective and emergency cases were 3.4 (38/1117) and 18% (27/150), respectively (P < 0.001). The type of aortic disease greatly affected the in-hospital mortality rate, being 3.1% for degenerative aneurysm, 13.3% for chronic dissection, 14% for acute dissection, 16.7% for active endocarditis and 25% for false aneurysm (P < 0.001). At least one major postoperative complication occurred in 204 patients (16%). A mechanical ventilation of >72 h was required in 7.8% (n = 79) of patients, and a definitive and a temporary dialysis was performed in 0.2% (n = 3) and in 4% (n = 51) of cases, respectively. A postoperative myocardial infarction occurred in 2.9% (n = 37) of patients, and a chest reopening for bleeding was performed in 5.3% (n = 67). Distribution of deaths and postoperative complications across type of operation (ARR versuss PRR) is illustrated in Table 4.

Table 4:

In-hospital outcomes across type of operation (n = 1267)

VariablesOverall cohort
Propensity-matched cohort
Redo (n = 180)Primary operation (n = 1087)AbRR%aOR (95% CI)P-valueRedo (n = 116)Primary operation (n = 116)AbRR%aOR (95% CI)P-value
In-hospital mortality rate11.14.172.9 (1.666–5.029)<0.00161.74.32.7 (0.744–18.009)0.2
Major complications22.215.17.11.6 (1.090–2.372)0.0216.414.71.71.1 (0.569–2.324)0.9
Mechanical ventilation >72 h11.17.141.6 (0.944–2.804)0.085.34.90.41.1 (0.295–3.955)0.6
Acute myocardial infarction3.92.71.22.4 (1.471–3.978)0.0013.121.11.6 (0.612–3.965)1
Temporary/permanent dialysis6.73.92.81.9 (1.203–3.248)0.011.71.700.7 (0.074–6.922)1
Permanent neurological deficit4.41.72.72.6 (1.127–6.066)0.040.92.6−1.70.3 (0.034–3.196)0.6
Bleeding8.94.74.21.9 (1.104–3.558)0.035.24.30.91.2 (0.359–4.084)1
Sepsis3.94.7−0.80.8 (0.367–1.841)0.83.43.9−0.50.9 (0.207–3.030)1
VariablesOverall cohort
Propensity-matched cohort
Redo (n = 180)Primary operation (n = 1087)AbRR%aOR (95% CI)P-valueRedo (n = 116)Primary operation (n = 116)AbRR%aOR (95% CI)P-value
In-hospital mortality rate11.14.172.9 (1.666–5.029)<0.00161.74.32.7 (0.744–18.009)0.2
Major complications22.215.17.11.6 (1.090–2.372)0.0216.414.71.71.1 (0.569–2.324)0.9
Mechanical ventilation >72 h11.17.141.6 (0.944–2.804)0.085.34.90.41.1 (0.295–3.955)0.6
Acute myocardial infarction3.92.71.22.4 (1.471–3.978)0.0013.121.11.6 (0.612–3.965)1
Temporary/permanent dialysis6.73.92.81.9 (1.203–3.248)0.011.71.700.7 (0.074–6.922)1
Permanent neurological deficit4.41.72.72.6 (1.127–6.066)0.040.92.6−1.70.3 (0.034–3.196)0.6
Bleeding8.94.74.21.9 (1.104–3.558)0.035.24.30.91.2 (0.359–4.084)1
Sepsis3.94.7−0.80.8 (0.367–1.841)0.83.43.9−0.50.9 (0.207–3.030)1

Values are percentages unless otherwise indicated.

AbRR: absolute risk reduction; CI: confidence interval; OR: odds ratio.

aAbRR negative value represents the per cent difference in mortality between patients undergoing reoperation and primary operation, in favour of reoperation group.

Table 4:

In-hospital outcomes across type of operation (n = 1267)

VariablesOverall cohort
Propensity-matched cohort
Redo (n = 180)Primary operation (n = 1087)AbRR%aOR (95% CI)P-valueRedo (n = 116)Primary operation (n = 116)AbRR%aOR (95% CI)P-value
In-hospital mortality rate11.14.172.9 (1.666–5.029)<0.00161.74.32.7 (0.744–18.009)0.2
Major complications22.215.17.11.6 (1.090–2.372)0.0216.414.71.71.1 (0.569–2.324)0.9
Mechanical ventilation >72 h11.17.141.6 (0.944–2.804)0.085.34.90.41.1 (0.295–3.955)0.6
Acute myocardial infarction3.92.71.22.4 (1.471–3.978)0.0013.121.11.6 (0.612–3.965)1
Temporary/permanent dialysis6.73.92.81.9 (1.203–3.248)0.011.71.700.7 (0.074–6.922)1
Permanent neurological deficit4.41.72.72.6 (1.127–6.066)0.040.92.6−1.70.3 (0.034–3.196)0.6
Bleeding8.94.74.21.9 (1.104–3.558)0.035.24.30.91.2 (0.359–4.084)1
Sepsis3.94.7−0.80.8 (0.367–1.841)0.83.43.9−0.50.9 (0.207–3.030)1
VariablesOverall cohort
Propensity-matched cohort
Redo (n = 180)Primary operation (n = 1087)AbRR%aOR (95% CI)P-valueRedo (n = 116)Primary operation (n = 116)AbRR%aOR (95% CI)P-value
In-hospital mortality rate11.14.172.9 (1.666–5.029)<0.00161.74.32.7 (0.744–18.009)0.2
Major complications22.215.17.11.6 (1.090–2.372)0.0216.414.71.71.1 (0.569–2.324)0.9
Mechanical ventilation >72 h11.17.141.6 (0.944–2.804)0.085.34.90.41.1 (0.295–3.955)0.6
Acute myocardial infarction3.92.71.22.4 (1.471–3.978)0.0013.121.11.6 (0.612–3.965)1
Temporary/permanent dialysis6.73.92.81.9 (1.203–3.248)0.011.71.700.7 (0.074–6.922)1
Permanent neurological deficit4.41.72.72.6 (1.127–6.066)0.040.92.6−1.70.3 (0.034–3.196)0.6
Bleeding8.94.74.21.9 (1.104–3.558)0.035.24.30.91.2 (0.359–4.084)1
Sepsis3.94.7−0.80.8 (0.367–1.841)0.83.43.9−0.50.9 (0.207–3.030)1

Values are percentages unless otherwise indicated.

AbRR: absolute risk reduction; CI: confidence interval; OR: odds ratio.

aAbRR negative value represents the per cent difference in mortality between patients undergoing reoperation and primary operation, in favour of reoperation group.

In-hospital mortality and morbidity rates: reoperation versus primary operation

To control for observed differences in patient characteristics, we estimated the probability of reoperation (PS) for each patient. After nearest-neighbour propensity-score matching without replacement, two groups of 116 patients each were created (ARR group versus PRR group). After propensity matching, standardized differences between covariates in the two treatment groups decreased substantially (Table 2, Fig. 2).
Balance in covariates before and after propensity matching. BAV: bicuspid aortic valve; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; IMH: intramural haematoma; NYHA: New York Heart Association; PVD: peripheral vascular disease; SDAM: standardized difference after matching; SDBM: standardized difference before matching; TAAD: type A acute aortic dissection.
Figure 2:

Balance in covariates before and after propensity matching. BAV: bicuspid aortic valve; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; IMH: intramural haematoma; NYHA: New York Heart Association; PVD: peripheral vascular disease; SDAM: standardized difference after matching; SDBM: standardized difference before matching; TAAD: type A acute aortic dissection.

The unadjusted comparison of hospital mortality and morbidity rates showed significant differences between groups (AbRR for hospital death: 7%, P < 0.001; AbRR for major postoperative complications: 7.1%, P = 0.02). Conversely, in the matched cohort, reoperation and primary operation were associated with a similar risk of in-hospital mortality and major postoperative complications (AbRR for hospital death: 4.3%, P = 0.2; AbRR for major postoperative complications: 1.7%, P = 0.9) (Table 4). This finding was confirmed after controlling for all measured covariates by standard logistic regression and for the estimated probability of reoperation (Table 5). After matching, all measured postoperative complications were similar in the two treatment groups (Table 4).

Table 5:

Unadjusted and adjusted odds ratio for hospital mortality rate and major postoperative complications: aortic root reoperation versus primary root replacement

Risk adjustment method for hospital mortality rate and major complications (ARR versus PRR)P-valueOdds ratio95% confidence interval
Hospital mortality
 Unadjusted<0.0012.91.666–5.029
 Standard logistic regressiona0.23.70.519–26.251
 Propensity-adjusted logistic regressionb0.51.40.599–3.079
Postoperative complications
 Unadjusted0.0021.61.090–2.372
 Standard logistic regressiona0.51.10.071–3.677
 Propensity-adjusted logistic regressionb0.91.10.614–1.779
Risk adjustment method for hospital mortality rate and major complications (ARR versus PRR)P-valueOdds ratio95% confidence interval
Hospital mortality
 Unadjusted<0.0012.91.666–5.029
 Standard logistic regressiona0.23.70.519–26.251
 Propensity-adjusted logistic regressionb0.51.40.599–3.079
Postoperative complications
 Unadjusted0.0021.61.090–2.372
 Standard logistic regressiona0.51.10.071–3.677
 Propensity-adjusted logistic regressionb0.91.10.614–1.779

ARR: aortic root reoperation; PRR: primary root replacement.

aLogistic regression against 15 measured covariates including type of operation (reoperation versus primary operation).

bLogistic regression against type of operation (reoperation versus primary operation) adjusted for the estimated probability of reoperation.

Table 5:

Unadjusted and adjusted odds ratio for hospital mortality rate and major postoperative complications: aortic root reoperation versus primary root replacement

Risk adjustment method for hospital mortality rate and major complications (ARR versus PRR)P-valueOdds ratio95% confidence interval
Hospital mortality
 Unadjusted<0.0012.91.666–5.029
 Standard logistic regressiona0.23.70.519–26.251
 Propensity-adjusted logistic regressionb0.51.40.599–3.079
Postoperative complications
 Unadjusted0.0021.61.090–2.372
 Standard logistic regressiona0.51.10.071–3.677
 Propensity-adjusted logistic regressionb0.91.10.614–1.779
Risk adjustment method for hospital mortality rate and major complications (ARR versus PRR)P-valueOdds ratio95% confidence interval
Hospital mortality
 Unadjusted<0.0012.91.666–5.029
 Standard logistic regressiona0.23.70.519–26.251
 Propensity-adjusted logistic regressionb0.51.40.599–3.079
Postoperative complications
 Unadjusted0.0021.61.090–2.372
 Standard logistic regressiona0.51.10.071–3.677
 Propensity-adjusted logistic regressionb0.91.10.614–1.779

ARR: aortic root reoperation; PRR: primary root replacement.

aLogistic regression against 15 measured covariates including type of operation (reoperation versus primary operation).

bLogistic regression against type of operation (reoperation versus primary operation) adjusted for the estimated probability of reoperation.

Predictors of all-cause in-hospital death and major postoperative complications

Using multivariate analysis, independent risk factors for hospital death were determined to be CPB time (OR: 1.03 per min; 95% confidence interval, CI: 1.013–1.041; P < 0.001) and urgent/emergent status (OR: 6.4; 95% CI: 1.093–37.684 P = 0.04). Age (OR: 1.07 per year; 95% CI: 1.006–1.132; P = 0.03) was the only risk factor for major postoperative complications.

DISCUSSION

Since 1968, aortic root replacement using the Bentall technique [12] has proved to be a safe and effective treatment for thoracic aortic disease [1921]. Over the last decades, the reinterventions on the thoracic aorta have risen quickly as a result of the increased incidence of aortic diseases in an ageing population, the increased use of biological aortic valves and root substitutes, and the increased use of techniques for valve-sparing aortic root reconstruction. Our series strongly confirms such a trend because the number of aortic reoperations has quadrupled during the study period (Fig. 1). As previously reported by others [5, 6], the main indications for surgery in ARR patients were progression of the aortic pathology and mechanical (non-infective false aneurysm) or infectious complications. Taking into account the long mean interval time between the last previous procedure and the actual reintervention (11 ± 9 years), and the fact that degenerative aneurysm and chronic dissection accounted for 75% of all ARR procedures, we determined that regular clinical and imaging follow-ups are mandatory in patients undergoing operations on the proximal thoracic aorta.

Published early results of patients undergoing aortic reoperation with root replacement are worse than those of patients undergoing first-time surgery. Hospital mortality rates range from 6.5 to 15% in patients undergoing reoperative aortic surgery [410] and from 2 to 4% in patients undergoing first-time aortic root replacement [1922]. Recently, Silva et al. [5] compared the impact of ascending aorta and aortic reoperation with root replacement on early and mid-term outcomes in patients undergoing aortic surgery. The hospital mortality rate was 12.1% in reoperative patients and 6.8% in patients undergoing a primary operation; major postoperative complications occurred in 24.1 and 16.9% of patients, respectively. Similarly, Etz et al. [4] reported on 435 patients undergoing aortic root repair, stratifying outcomes according to the type of intervention (reoperation versus primary operation). The hospital mortality rate was 7% in the reoperative group and 3% in the first-time surgery group; the postoperative complication rate was 21 and 17%, respectively. In our study, we assessed outcomes in a selected group of patients undergoing aortic root surgery. Unlike the above-mentioned series, patients underwent aortic valve and ascending aorta replacement; patients who had previously undergone non-aortic surgery were excluded from the analysis. Hence, the substantial differences in the study populations do not allow us to compare our outcomes with those of the Mount Sinai [4] and Madrid [5] groups.

In our unmatched cohort, the outcomes of patients undergoing reoperations were poorer than those of patients having a primary operation. Hospital mortality (AbRR: 7%, P < 0.001) and postoperative complication rates (AbRR: 7%, P = 0.002) were worse in ARR patients than in PRR patients, which highlights the complexity of referred patients and of contemplated procedures in the ARR group. Conversely, in the matched cohort, reoperation and primary operation were associated with a similar risk of in-hospital mortality rates (AbRR: 4%, P = 0.2) and major postoperative complications (AbRR: 2%, P = 0.9). These findings were strengthened after controlling for all other measured covariates by standard logistic regression and by the estimated probability (PS) of reoperation. We may speculate that the different hospital outcomes between ARR and PRR patients were mostly influenced by diversity in patients' profiles and type of aortic disease. In this setting, the early mortality rate was very low in patients who presented with degenerative aneurysm (3.1%), and dismal in patients with false aneurysm (25%) or active endocarditis (16.7%) (P < 0.001). In the ARR group, the cumulative incidence of active endocarditis and false aneurysm was 22.2%, compared with only 0.7% in the PRR group (P < 0001). In contrast, considering that urgent/emergent status was the most relevant predictor of hospital deaths (OR: 6.4), almost 90% of PRR patients had a degenerative aneurysm and underwent elective surgery. Furthermore, CPB time was confirmed to be an intraoperative predictor of mortality (OR: 1.03 per min; P < 0.001) and likely acted as a surrogate for demanding reinterventions such as those performed in patients with active endocarditis and aortic dissection. Our findings confirm that aortic reoperation in patients with active endocarditis remains a major concern [23], but, in this setting, current evidence is not yet strong enough to demonstrate what is the most effective management technique—surgical or medical therapy.

In aortic reoperations with root replacement, likely more than in other cardiac interventions, an effective method of myocardial protection can improve postoperative outcomes. In recent series, myocardial failure was the major cause of death in patients undergoing reoperations on the aortic root [8], and unplanned coronary artery bypass graft (CABG) was associated with operative mortality due to myocardial failure [24]. The main concern involves patients with significant aortic insufficiency, in which preventing (or delaying) ventricular fibrillation, and therefore left ventricle distension, decreases the risk of myocardial dysfunction at the end of the operation. In this setting, in ARR patients in whom the ascending aorta (or graft) could not be isolated and clamped quickly, distension of the left ventricle was avoided by venting the apex of the heart through a small left thoracotomy. In patients in whom the coronary artery ostia are detached, dissected or involved in the infectious process, selective antegrade administration of cardioplegia should be carried out with care, and retrograde or percutaneous infusion of cardioplegia through the coronary sinus should be considered [25]. Moreover, if difficulties in administering cardioplegia are expected with all methods, a lower core temperature provides additional time for myocardial protection to address the complex situation more effectively. Using these strategies, in our matched cohort, we did not observe a higher rate of acute myocardial infarction or unplanned CABG in ARR patients.

Limitations

The present study has several limitations of which retrospective design and statistical methods represent the most critical. Only randomized controlled trials may simultaneously guarantee prospective data and account for all differences between treatment groups. Propensity analysis is a powerful statistical technique, but it is limited by the number and accuracy of the assessed variables. Furthermore, PS analysis dismissed the sample size of the series and a type II error may have been generated. The statistical power of combined end-point ‘postoperative complications’ may be limited by the low event rate for each variable included. However, it is worth noting that in our analysis a considerable number of plausible preoperative and intraoperative covariates were used to compute the PS, and post-matching covariate balance was excellent. This study assesses the effectiveness of our surgical treatment in patients undergoing aortic root reoperations with root replacement and provides relevant evidence in this setting. Nevertheless, our findings cannot be generalized to the whole cardiac surgery community. There is growing evidence supporting the observation that outcomes following complex aortic procedures are improved at high-volume centres [26]. Patients who require aortic reoperations with root replacement should be referred to these centres.

CONCLUSION

Our study indicated that reoperation did not affect outcomes in patients undergoing aortic root surgery operated on at a high-volume aortic centre by experienced surgeons. In this setting, hospital results were heavily influenced by aortic pathology and the patient's profile. Although patients who presented with degenerative aneurysm were associated with satisfactory outcomes, those affected by false aneurysm and active endocarditis remain associated with high rates of postoperative mortality and morbidity.

Conflict of interest: none declared.

REFERENCES

1

Dougenis
D
,
Daily
BB
,
Kouchoukos
NT
.
Reoperations on the aortic root and ascending aorta
.
Ann Thorac Surg
1997
;
64
:
986
92
.

2

Di Bartolomeo
R
,
Berretta
P
,
Petridis
FD
,
Folesani
G
,
Cefarelli
M
,
Di Marco
L
et al.
Reoperative surgery on the thoracic aorta
.
J Thorac Cardiovasc Surg
2013
;
145
(3 Suppl)
:
S78
84
.

3

Shrestha
M
,
Khaladj
N
,
Baraki
H
,
Al Ahmad
A
,
Koigeldiyev
N
,
Pichlmaier
M
et al.
Aortic root reoperation: a technical challenge
.
J Heart Valve Dis
2010
;
19
:
177
81
.

4

Etz
CD
,
Plestis
KA
,
Homann
TM
,
Bodian
CA
,
Di Luozzo
G
,
Spielvogel
D
et al.
Reoperative aortic root and transverse arch procedures: a comparison with contemporaneous primary operations
.
J Thorac Cardiovasc Surg
2008
;
136
:
860
7
,
867.e1-3
.

5

Silva
J
,
Maroto
LC
,
Carnero
M
,
Vilacosta
I
,
Cobiella
J
,
Villagrán
E
et al.
Ascending aorta and aortic root reoperations: are outcomes worse than first time surgery?
Ann Thorac Surg
2010
;
90
:
555
60
.

6

Schepens
MA
,
Dossche
KM
,
Morshuis
WJ
.
Reoperations on the ascending aorta and aortic root: pitfalls and results in 134 patients
.
Ann Thorac Surg
1999
;
68
:
1676
80
.

7

Malvindi
PG
,
van Putte
BP
,
Heijmen
RH
,
Schepens
MAAM
,
Morshuis
WJ
.
Reoperations on the aortic root: experience in 46 patients
.
Ann Thorac Surg
2010
;
89
:
81
6
.

8

Luciani
N
,
De Geest
R
,
Anselmi
A
,
Glieca
F
,
De Paulis
S
,
Possati
G
.
Results of reoperation on the aortic root and the ascending aorta
.
Ann Thorac Surg
2011
;
92
:
898
903
.

9

LeMaire
SA
,
DiBardino
DJ
,
Köksoy
C
,
Coselli
JS
.
Proximal aortic reoperations in patients with composite valve grafts
.
Ann Thorac Surg
2002
;
74
:
S1777
80
;
discussion S1792-9
.

10

Di Eusanio
M
,
Berretta
P
,
Cefarelli
M
,
Folesani
G
,
Petridis
FD
,
Di Marco
L
et al.
Reoperative aortic root replacement: short- and long-term outcomes in 111 patients
.
G Ital Cardiol (Rome)
2012
;
13
:
745
50
.

11

Di Eusanio
M
,
Schepens
MA
,
Morshuis
WJ
,
Di Bartolomeo
R
,
Pierangeli
A
,
Dossche
KM
.
Antegrade selective cerebral perfusion during operations on the thoracic aorta: factors influencing survival and neurologic outcome in 413 patients
.
J Thorac Cardiovasc Surg
2002
;
124
:
1080
6
.

12

Bentall
H
,
De Bono
A
.
A technique for complete replacement of the ascending aorta
.
Thorax
1968
;
23
:
338
9
.

13

Kouchoukos
NT
,
Wareing
TH
,
Murphy
SF
,
Perrillo
JB
.
Sixteen-year experience with aortic root replacement. Results of 172 operations
.
Ann Surg
1991
;
214
:
308
18
;
discussion 318-20
.

14

Cabrol
C
,
Pavie
A
,
Gandjbakhch
I
,
Villemot
JP
,
Guiraudon
G
,
Laughlin
L
et al.
Complete replacement of the ascending aorta with reimplantation of the coronary arteries: new surgical approach
.
J Thorac Cardiovasc Surg
1981
;
81
:
309
15
.

15

Di Eusanio
M
,
Berretta
P
,
Cefarelli
M
,
Di Bartolomeo
R
.
Root graft substitution after aortic valve replacement: sparing the valve prosthesis is a valid option
.
Eur J Cardiothorac Surg
2013
;
44
:
427
30
.

16

Di Eusanio
M
,
Schepens
MA
,
Morshuis
WJ
,
Dossche
KM
,
Kazui
T
,
Ohkura
K
et al.
Separate grafts or en bloc anastomosis for arch vessels reimplantation to the aortic arch
.
Ann Thorac Surg
2004
;
77
:
2021
8
.

17

Di Eusanio
M
,
Pantaleo
A
,
Murana
G
,
Pellicciari
G
,
Castrovinci
S
,
Berretta
P
et al.
Frozen elephant trunk surgery-the Bologna's experience
.
Ann Cardiothorac Surg
2013
;
2
:
597
605
.

18

Austin
PC
.
Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement
.
J Thorac Cardiovasc Surg
2007
;
134
:
1128
35
.

19

Gleason
TG
,
David
TE
,
Coselli
JS
,
Hammon
JW
,
Bavaria
JE
.
St. Jude Medical Toronto biologic aortic root prosthesis: early FDA phase II IDE study results
.
Ann Thorac Surg
2004
;
78
:
786
93
.

20

Sioris
T
,
David
TE
,
Ivanov
J
,
Armstrong
S
,
Feindel
CM
.
Clinical outcomes after separate and composite replacement of the aortic valve and ascending aorta
.
J Thorac Cardiovasc Surg
2004
;
128
:
260
5
.

21

Zehr
KJ
,
Orszulak
TA
,
Mullany
CJ
,
Matloobi
A
,
Daly
RC
,
Dearani
JA
et al.
Surgery for aneurysms of the aortic root: a 30-year experience
.
Circulation
2004
;
110
:
1364
71
.

22

Kindo
M
,
Billaud
P
,
Gerelli
S
,
Levy
F
,
Mazzucotelli
JP
,
Eisenmann
B
.
Twenty-seven-year experience with composite valve graft replacement of the aortic root
.
J Heart Valve Dis
2007
;
16
:
370
7
.

23

Di Eusanio
M
,
Berretta
P
,
Bissoni
L
,
Petridis
FD
,
Di Marco
L
,
Di Bartolomeo
R
.
Re-operations on the proximal thoracic aorta: results and predictors of short- and long-term mortality in a series of 174 patients
.
Eur J Cardiothorac Surg
2011
;
40
:
1072
6
.

24

Kirsch
EW
,
Radu
NC
,
Mekontso-Dessap
A
,
Hillion
ML
,
Loisance
D
.
Aortic root replacement after previous surgical intervention on the aortic valve, aortic root, or ascending aorta
.
J Thorac Cardiovasc Surg
2006
;
131
:
601
8
.

25

Maselli
D
,
Santise
G
,
Montalto
A
,
Musumeci
F
.
Endovascular aortic clamping for pseudoaneurysms of the aortic root with aortic regurgitation
.
Ann Thorac Surg
2005
;
80
:
1303
8
.

26

Hughes
GC
,
Zhao
Y
,
Rankin
JS
,
Scarborough
JE
,
O'Brien
S
,
Bavaria
JE
et al.
Effects of institutional volumes on operative outcomes for aortic root replacement in North America
.
J Thorac Cardiovasc Surg
2013
;
145
:
166
70
.